iCARE: An R package to build, validate and apply absolute risk models | PLOS ONE
Frontiers | Implications of Lifestyle Factors and Polygenic Risk Score for Absolute Risk Prediction of Colorectal Neoplasm and Risk-Adapted Screening
Figure 6, Pooled absolute risk differences of antibiotic resistance in humans - WHO Guidelines on Use of Medically Important Antimicrobials in Food-Producing Animals - NCBI Bookshelf
Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease - ScienceDirect
Risk Differences and Rate Differences
ODYSSEY OUTCOMES and Clinical Data | PRALUENT® (alirocumab) Injection
Numbers needed to treat (NNT) with 95% confidence intervals (CI),... | Download Table
Frontiers | Primary Absolute Cardiovascular Disease Risk and Prevention in Relation to Psychological Distress in the Australian Population: A Nationally Representative Cross-Sectional Study
Effects of presenting risk information in different formats to cardiologists. A Latin American survey | Archivos de Cardiología de México
Clinical Trial for CDI Patients at High Risk for Recurrence
Change in relative risk with increasing distance and absolute risk with... | Download Scientific Diagram
Confidence intervals for the number needed to treat | The BMJ
Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Individual and community-level risk for COVID-19 mortality in the United States | Nature Medicine
The Continuum of Maternal Sepsis Severity: Incidence and Risk Factors in a Population-Based Cohort Study | PLOS ONE
Oncotype DX Breast Cancer Test Less Accurate for Blacks - NCI
MOVER-R confidence intervals for ratios and products of two independently estimated quantities - Robert G Newcombe, 2016
30-day mortality and morbidity in COVID-19 versus influenza: A population- based study | medRxiv
Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness | PLOS Medicine
